Publications by authors named "L Ibba"

Claim this Profile
C
Cumulative clinical benefits of biologic treatments in patients with moderate-to-severe psoriasis: an Italian real-life experience - IL PSO (Italian Landscape Psoriasis).
Diego Orsini, Luca Potestio, Maria Concetta Fargnoli, Alessandra Narcisi, Luciano Ibba

Clin Exp Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risankizumab differentially modulates circulating T-cell populations in psoriasis according to autoreactivity status.
Rebecca Favaro, Paola Facheris, Alessandra Formai, Luigi Gargiulo, Luciano Ibba

J Dermatol Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Life Effectiveness and Safety of Bimekizumab in Plaque Psoriasis Involving Difficult-to-Treat Areas: A 52-Week, Retrospective Real-World, Single-Center Study.
Matteo Bianco, Francesco D'Oria, Gioele Ghezzi, Luciano Ibba, Sara Di Giulio

J Clin Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Super-Responder Status to Anti-IL-23 Therapies in Moderate-to-Severe Plaque Psoriasis: A Real-World Monocenter Study.
Sara Di Giulio, Costanza Falcidia, Giulio Foggi, Matteo Bianco, Luigi Gargiulo, Luciano Ibba

J Clin Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Hagino et al.: 'Importance of Upadacitinib dose escalation prior to switch to lebrikizumab'.
Luigi Gargiulo, Matteo Bianco, Luciano Ibba, Mario Valenti, Paola Facheris

J Eur Acad Dermatol Venereol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis